Second lung adenocarcinoma after combination chemotherapy in two patients with primary non-Hodgkin's lymphoma

Japanese Journal of Clinical Oncology

Volumn 29, Issue 4, 1999, Pages 226-228

  Yamada, Tetsuya ^a   Shinohara, Kenji ^a   Takeda, Koumei ^a   Kameda, Naoko ^a   Katsuki, Kensaku ^a   Ariyoshi, Kouichi ^a   Kamei, Toshiaki ^a  

^a Yamaguchi Pref Central Hospital   (Japan)

Author keywords

Combination chemotherapy; Lung adenocarcinoma; Malignant lymphoma; Second malignant neoplasm

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CHOP PROTOCOL; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DHAP PROTOCOL; DOXORUBICIN; FOLINIC ACID; M BACOD PROTOCOL; M-BACOD PROTOCOL; METHOTREXATE; PREDNISONE; VINCRISTINE;

ADENOCARCINOMA; AGED; ARTICLE; CASE REPORT; DRUG ADMINISTRATION; FEMALE; HUMAN; LARGE CELL LYMPHOMA; LUNG TUMOR; LYMPHOCYTOMA; MALE; MIDDLE AGED; SECOND CANCER; SPINAL CORD TUMOR;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LEUCOVORIN; LUNG NEOPLASMS; LYMPHOMA, LARGE-CELL, DIFFUSE; LYMPHOMA, SMALL CLEAVED-CELL, DIFFUSE; MALE; METHOTREXATE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PREDNISONE; SPINAL CORD NEOPLASMS; VINCRISTINE;

EID: 0033113238     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/29.4.226     Document Type: Article

References (19)

1. Pedersen-Bjergaard J, Larsen SO. Incidence of acute nonlymphocytic leukemia, preleukemia and acute myeloproliferative syndrome up to 10 years after treatment of Hodgkin's disease. N Engl J Med 1982;307:965-71.
2. Li FP. Second malignant tumors after cancer in childhood. Cancer 1977;40:1899-1902.
3. Mike V, Meadows AT, D'Angio GJ. Incidence of second malignant neoplasms in children: results of an international study. Lancet 1982;ii:1326-30.
4. Konits PH, Aisner J, Whitacre M, Wiernik PH. Lung cancer as a complication of prolonged survival in patients with lymphoma. Med Pediat Oncol 1982;10:331-8.
5. List AF, Doll DC, Greco FA. Lung cancer in Hodgkin's disease: association with previous radiotherapy. J Clin Oncol 1985;3:215-21.
6. Kingston JE, Hawkins MM, Draper GJ, Marsden HB, Wilson LMK. Patterns of multiple primary tumors in patients treated for cancer during childhood. Br J Cancer 1987;56:331-8.
7. Hawkins MM, Draper GJ, Kingston JE. Incidence of second primary tumors among childhood cancer survivors. Br J Cancer 1987;56:339-17.
8. van Leeuwen FE, Somers R, Taal BG, van Heerde P, Coster B, Dozeman T, et al. Increased risk of lung cancer, non-Hodgkin's lymphoma and leukemia following Hodgkin's disease. J Clin Oncol 1989;7:1046-58.
9. Neglia JP, Meadows AT, Robinson LL, Kin TH, Newton WA, Ruymann FB, et al. Second neoplasms after acute lymphoblastic leukemia in childhood. N Engl J Med 1991;325:1330-6.
10. Kaldor JM, Day NE, Bell J, Clarke EA, Langmark F, Karialainen S, et al. Luna cancer following Hodakin's disease: a case-control study. Int J Cancer 1992;52:677-81.
11. Beaty O III, Hudson MM, Greenwald C, Luo X, Fang L, Williams JA, et al. Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease. J Clin Oncol 1995;13:603-9.
12. Pratt CB, Meyer WH, Luo X, Cain AM, Kate SC, Pappo AS, et al. Second malignant neoplasms occuring in survivors of osteosarcoma. Cancer 1997;80:960-5.
13. Fine HA. Treatment of primary central nervous system lymphoma; still more questions than answers. Blood 1995;86:2873-5.
14. Srivastava S, Zou Z, Pirollo K, Blattner W, Chang EH. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 1990;348:347-9.
15. Malkin D, Jolly KW, Barbier N, Look T, Friend SH, Gerhardt MC, et al. Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. N Engl J Med 1992;326:1309-15.
16. Russo CL, McIntyre J, Goorin AM, Link MP, Gebhardt MC, Friend SH. Secondary breast cancer in patients presenting with osteosarcoma: possible involvement of germline p53 mutations. Med Pediat Oncol 1994;23:354-8.
17. Deeg HJ, Socie G. Malignancies after hematopoietic stem cell transplantation: many questions, some answers. Blood 1998;91:1833-44.
18. Andre M, Henry-Amar M, Blaise D, Colombat P, Fleury J, Milpied N, et al. Incidence of second cancer (CS) and causes of death after autologous stem cell transplantation (ASCT) for Hodgkin's disease (HD). Blood 1995;86:460a.
19. Curtis R E, Rowlings P A, Deeg H J, Schriner D A, Socie G, Travis L B, et al. Solid cancers after bone marrow transplantation. N Engl J Med 1997;336:897-904.